Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ATXS
Stock Latest News
Company Announcements
Astria Therapeutics Reports Q3 2025 Results and BioCryst Acquisition
15d ago
ATXS
Premium
Ratings
Astria Therapeutics: Hold Rating Amid Acquisition and Financial Stability with Future Growth Prospects
15d ago
ATXS
Premium
The Fly
Astria Therapeutics downgraded to Neutral from Overweight at Cantor Fitzgerald
16d ago
ATXS
Premium
Pre-Earnings
Is ATXS a Buy, Before Earnings?
18d ago
ATXS
Premium
The Fly
Astria Therapeutics announces final results from ALPHA-STAR trial
22d ago
ATXS
Premium
Company Announcements
Astria Therapeutics Advances Phase 3 Trial for Hereditary Angioedema Treatment
1M ago
ATXS
Premium
Company Announcements
Astria Therapeutics Advances Phase 3 Trial for Hereditary Angioedema Treatment
1M ago
ATXS
Premium
Company Announcements
Astria Therapeutics’ STAR-0310 Study: A Promising Step Forward
1M ago
ATXS
Premium
The Fly
Astria Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
1M ago
ATXS
Premium
The Fly
BioCryst price target raised to $26 from $24 at Cantor Fitzgerald
1M ago
ATXS
BCRX
Premium
The Fly
Astria Therapeutics downgraded to Neutral from Outperform at Wedbush
1M ago
ATXS
Premium
The Fly
BioCryst price target raised to $27 from $17 at Citizens JMP
1M ago
ATXS
BCRX
Premium
The Fly
Astria downgraded to Market Perform from Outperform at Citizens JMP
1M ago
ATXS
Premium
The Fly
BioCryst reinstated with a Buy at TD Cowen
1M ago
ATXS
BCRX
Premium
The Fly
Astria Therapeutics downgraded to Perform from Outperform at Oppenheimer
1M ago
ATXS
Premium
The Fly
BioCryst weakness presents ‘compelling’ buying opportunity, says RBC
1M ago
ATXS
BCRX
Premium
Ratings
Strategic Acquisition of Astria Therapeutics by BioCryst Pharmaceuticals Highlights Potential of Navenibart for HAE Prophylaxis
1M ago
ATXS
Premium
The Fly
BioCryst price target raised to $15 from $14 at Jefferies
1M ago
ATXS
BCRX
Premium
Ratings
Hold Rating on BCRX Amid Strategic Acquisition of Astria Therapeutics and Market Challenges
1M ago
ATXS
Premium
The Fly
Astria Therapeutics downgraded to Hold from Buy at Jefferies
1M ago
ATXS
BCRX
Premium
Market News
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
1M ago
MU
AMD
Premium
The Fly
Midday Fly By: Big banks report beats, GM takes $1.6B EV charge
1M ago
C
F
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
